{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 47, "transaction_limit": 160, "filters": {"q": "", "ticker": "", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 47, "acquisition_count": 35, "disposal_count": 12, "acquisition_value": 3614840.7291, "acquisition_value_label": "$3.6M", "disposal_value": 8619042.664, "disposal_value_label": "$8.6M", "net_value": -5004201.9349, "net_value_label": "$-5.0M", "flow_tone": "negative", "largest_value_label": "$5.8M", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 47, "value": "12233883.3931", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$12.2M"}], "days": [{"transaction_date": "2026-06-26", "acquisitions": 8, "disposals": 1, "total": 9, "bar_width": 64.3}, {"transaction_date": "2026-06-30", "acquisitions": 11, "disposals": 0, "total": 11, "bar_width": 78.6}, {"transaction_date": "2026-07-01", "acquisitions": 8, "disposals": 6, "total": 14, "bar_width": 100.0}, {"transaction_date": "2026-07-09", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 7.1}, {"transaction_date": "2026-07-15", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 21.4}, {"transaction_date": "2026-07-20", "acquisitions": 6, "disposals": 3, "total": 9, "bar_width": 64.3}], "side_mix": {"acquisitions": 35, "disposals": 12, "acquisition_share": 74.5, "disposal_share": 25.5}}, "company_flows": [{"symbol": "GILD", "name": "Gilead Sciences Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-15", "acquisitions": 0, "disposals": 4, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 2673934.33, "disposed_value_label": "$2.7M", "net_value": -2673934.33, "net_value_label": "$-2.7M", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/gild/", "research_links": {"chart": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/", "report": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/report/", "factor": "/factors/ticker/bed0290f-10c3-46eb-9ae3-e4a990955009/"}}, {"symbol": "JNJ", "name": "Johnson & Johnson", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-20", "acquisitions": 2, "disposals": 3, "acquired_value": 3014701.29, "acquired_value_label": "$3.0M", "disposed_value": 5792686.364, "disposed_value_label": "$5.8M", "net_value": -2777985.074, "net_value_label": "$-2.8M", "acquisition_share": 40.0, "disposal_share": 60.0, "detail_url": "https://sharemaestro.com/insider-activity/company/jnj/", "research_links": {"chart": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/", "report": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/report/", "factor": "/factors/ticker/faf43de1-aad0-4aa0-98eb-93c011d3d249/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-15", "acquisitions": 9, "disposals": 0, "acquired_value": 258234.6707, "acquired_value_label": "$258.2K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 258234.6707, "net_value_label": "$258.2K", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "BMY", "name": "Bristol-Myers Squibb Company", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-06-30", "acquisitions": 5, "disposals": 0, "acquired_value": 195000.0242, "acquired_value_label": "$195.0K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 195000.0242, "net_value_label": "$195.0K", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/bmy/", "research_links": {"chart": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/", "report": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/report/", "factor": "/factors/ticker/d302e92e-0d9f-411a-8823-7efba73d07cd/"}}, {"symbol": "MRK", "name": "Merck & Company Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-06-30", "acquisitions": 3, "disposals": 0, "acquired_value": 54374.9935, "acquired_value_label": "$54.4K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 54374.9935, "net_value_label": "$54.4K", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/mrk/", "research_links": {"chart": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/", "report": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/report/", "factor": "/factors/ticker/f6db1008-c56f-44d2-9216-b4268cb66ffa/"}}, {"symbol": "ABBV", "name": "AbbVie Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-06-30", "acquisitions": 2, "disposals": 0, "acquired_value": 49321.44, "acquired_value_label": "$49.3K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 49321.44, "net_value_label": "$49.3K", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/abbv/", "research_links": {"chart": "/terminal/9a54a5f7-3445-44e1-a263-af644888772e/", "report": "/terminal/9a54a5f7-3445-44e1-a263-af644888772e/report/", "factor": "/factors/ticker/9a54a5f7-3445-44e1-a263-af644888772e/"}}, {"symbol": "LLY", "name": "Eli Lilly and Company", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-20", "acquisitions": 4, "disposals": 0, "acquired_value": 43208.3107, "acquired_value_label": "$43.2K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 43208.3107, "net_value_label": "$43.2K", "acquisition_share": 100.0, "disposal_share": 0.0, "detail_url": "https://sharemaestro.com/insider-activity/company/lly/", "research_links": {"chart": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/", "report": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/report/", "factor": "/factors/ticker/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-01", "acquisitions": 5, "disposals": 5, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 152421.97, "disposed_value_label": "$152.4K", "net_value": -152421.97, "net_value_label": "$-152.4K", "acquisition_share": 50.0, "disposal_share": 50.0, "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}], "company_overview": [{"symbol": "JNJ", "name": "Johnson & Johnson", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "exchange": "NYSE", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-20", "filings": 5, "acquisitions": 2, "disposals": 3, "acquired_value": 3014701.29, "acquired_value_label": "$3.0M", "disposed_value": 5792686.364, "disposed_value_label": "$5.8M", "net_value": -2777985.074, "net_value_label": "$-2.8M", "acquisition_share": 40.0, "disposal_share": 60.0, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/jnj/", "research_links": {"chart": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/", "report": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/report/", "factor": "/factors/ticker/faf43de1-aad0-4aa0-98eb-93c011d3d249/"}}, {"symbol": "LLY", "name": "Eli Lilly and Company", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "exchange": "NYSE", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-20", "filings": 4, "acquisitions": 4, "disposals": 0, "acquired_value": 43208.3107, "acquired_value_label": "$43.2K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 43208.3107, "net_value_label": "$43.2K", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/lly/", "research_links": {"chart": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/", "report": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/report/", "factor": "/factors/ticker/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "exchange": "NYSE", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-15", "filings": 9, "acquisitions": 9, "disposals": 0, "acquired_value": 258234.6707, "acquired_value_label": "$258.2K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 258234.6707, "net_value_label": "$258.2K", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "GILD", "name": "Gilead Sciences Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-15", "filings": 4, "acquisitions": 0, "disposals": 4, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 2673934.33, "disposed_value_label": "$2.7M", "net_value": -2673934.33, "net_value_label": "$-2.7M", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/gild/", "research_links": {"chart": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/", "report": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/report/", "factor": "/factors/ticker/bed0290f-10c3-46eb-9ae3-e4a990955009/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-07-01", "filings": 15, "acquisitions": 10, "disposals": 5, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 152421.97, "disposed_value_label": "$152.4K", "net_value": -152421.97, "net_value_label": "$-152.4K", "acquisition_share": 66.7, "disposal_share": 33.3, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "BMY", "name": "Bristol-Myers Squibb Company", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "exchange": "NYSE", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-06-30", "filings": 5, "acquisitions": 5, "disposals": 0, "acquired_value": 195000.0242, "acquired_value_label": "$195.0K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 195000.0242, "net_value_label": "$195.0K", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/bmy/", "research_links": {"chart": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/", "report": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/report/", "factor": "/factors/ticker/d302e92e-0d9f-411a-8823-7efba73d07cd/"}}, {"symbol": "MRK", "name": "Merck & Company Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "exchange": "NYSE", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-06-30", "filings": 3, "acquisitions": 3, "disposals": 0, "acquired_value": 54374.9935, "acquired_value_label": "$54.4K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 54374.9935, "net_value_label": "$54.4K", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/mrk/", "research_links": {"chart": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/", "report": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/report/", "factor": "/factors/ticker/f6db1008-c56f-44d2-9216-b4268cb66ffa/"}}, {"symbol": "ABBV", "name": "AbbVie Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "exchange": "NYSE", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-general/", "latest_transaction": "2026-06-30", "filings": 2, "acquisitions": 2, "disposals": 0, "acquired_value": 49321.44, "acquired_value_label": "$49.3K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 49321.44, "net_value_label": "$49.3K", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/abbv/", "research_links": {"chart": "/terminal/9a54a5f7-3445-44e1-a263-af644888772e/", "report": "/terminal/9a54a5f7-3445-44e1-a263-af644888772e/report/", "factor": "/factors/ticker/9a54a5f7-3445-44e1-a263-af644888772e/"}}], "transactions": [{"symbol": "JNJ", "name": "Johnson & Johnson", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "BROADHURST, VANESSA", "executive_title": "EVP, Global Corp Affairs", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 23054.0, "share_price": 251.266, "transaction_value": 5792686.364, "fetched_at": "2026-07-30T22:11:04.070647+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/jnj/", "research_links": {"chart": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/", "report": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/report/", "factor": "/factors/ticker/faf43de1-aad0-4aa0-98eb-93c011d3d249/"}}, {"symbol": "JNJ", "name": "Johnson & Johnson", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "BROADHURST, VANESSA", "executive_title": "EVP, Global Corp Affairs", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 11925.0, "share_price": 131.94, "transaction_value": 1573384.5, "fetched_at": "2026-07-30T22:11:04.059226+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/jnj/", "research_links": {"chart": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/", "report": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/report/", "factor": "/factors/ticker/faf43de1-aad0-4aa0-98eb-93c011d3d249/"}}, {"symbol": "JNJ", "name": "Johnson & Johnson", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "BROADHURST, VANESSA", "executive_title": "EVP, Global Corp Affairs", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 11129.0, "share_price": 129.51, "transaction_value": 1441316.79, "fetched_at": "2026-07-30T22:11:04.063364+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/jnj/", "research_links": {"chart": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/", "report": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/report/", "factor": "/factors/ticker/faf43de1-aad0-4aa0-98eb-93c011d3d249/"}}, {"symbol": "LLY", "name": "Eli Lilly and Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "LUCIANO, JUAN R", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 13.878, "share_price": 1146.9, "transaction_value": 15916.6782, "fetched_at": "2026-07-30T22:10:55.753932+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lly/", "research_links": {"chart": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/", "report": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/report/", "factor": "/factors/ticker/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/"}}, {"symbol": "LLY", "name": "Eli Lilly and Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "ALVAREZ, RALPH", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10.8263, "share_price": 1146.9, "transaction_value": 12416.6835, "fetched_at": "2026-07-30T22:10:55.748992+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lly/", "research_links": {"chart": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/", "report": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/report/", "factor": "/factors/ticker/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/"}}, {"symbol": "LLY", "name": "Eli Lilly and Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "FYRWALD, J ERIK", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8.6465, "share_price": 1146.9, "transaction_value": 9916.6709, "fetched_at": "2026-07-30T22:10:55.744905+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lly/", "research_links": {"chart": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/", "report": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/report/", "factor": "/factors/ticker/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/"}}, {"symbol": "LLY", "name": "Eli Lilly and Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "SULZBERGER, GABRIELLE", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 4.3232, "share_price": 1146.9, "transaction_value": 4958.2781, "fetched_at": "2026-07-30T22:10:55.751244+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lly/", "research_links": {"chart": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/", "report": "/terminal/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/report/", "factor": "/factors/ticker/a3de1341-9ac3-48e9-b8c9-18c93f3d6516/"}}, {"symbol": "JNJ", "name": "Johnson & Johnson", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "BROADHURST, VANESSA", "executive_title": "EVP, Global Corp Affairs", "security_type": "Employee Stock Options (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 11925.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:11:04.065835+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/jnj/", "research_links": {"chart": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/", "report": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/report/", "factor": "/factors/ticker/faf43de1-aad0-4aa0-98eb-93c011d3d249/"}}, {"symbol": "JNJ", "name": "Johnson & Johnson", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-20", "executive": "BROADHURST, VANESSA", "executive_title": "EVP, Global Corp Affairs", "security_type": "Employee Stock Options (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 11129.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:11:04.068232+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/jnj/", "research_links": {"chart": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/", "report": "/terminal/faf43de1-aad0-4aa0-98eb-93c011d3d249/report/", "factor": "/factors/ticker/faf43de1-aad0-4aa0-98eb-93c011d3d249/"}}, {"symbol": "GILD", "name": "Gilead Sciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-15", "executive": "DICKINSON, ANDREW D", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3000.0, "share_price": 129.9256, "transaction_value": 389776.8, "fetched_at": "2026-07-31T10:46:08.466912+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/gild/", "research_links": {"chart": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/", "report": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/report/", "factor": "/factors/ticker/bed0290f-10c3-46eb-9ae3-e4a990955009/"}}, {"symbol": "GILD", "name": "Gilead Sciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-15", "executive": "MERCIER, JOHANNA", "executive_title": "Chief Comm & Corp Aff Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3000.0, "share_price": 129.9192, "transaction_value": 389757.6, "fetched_at": "2026-07-31T10:46:08.463412+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/gild/", "research_links": {"chart": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/", "report": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/report/", "factor": "/factors/ticker/bed0290f-10c3-46eb-9ae3-e4a990955009/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-15", "executive": "BOURLA, ALBERT", "executive_title": "Director, Chairman & CEO", "security_type": "Phantom Stock Units SSP", "side_code": "A", "side": "Acquisition", "shares": 24.0, "share_price": 24.82, "transaction_value": 595.68, "fetched_at": "2026-07-31T10:46:17.373310+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-09", "executive": "BOURLA, ALBERT", "executive_title": "Director, Chairman & CEO", "security_type": "Phantom Stock Units SSP", "side_code": "A", "side": "Acquisition", "shares": 84.0, "share_price": 24.25, "transaction_value": 2037.0, "fetched_at": "2026-07-29T11:03:03.035583+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "FISHMAN, PETER L.", "executive_title": "SVP, CFO", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 2447.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-22T22:00:10.530785+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "KEENAN, DAVID PAUL", "executive_title": "EVP, Chief Operating Officer", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 3688.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-22T22:00:10.542305+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "KETCHUM, STEVEN B", "executive_title": "EVP, Chief Scientific Officer", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 3688.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-22T22:00:10.538515+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "PROVOOST, JONATHAN", "executive_title": "EVP, Chief Legal Officer", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 3688.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-22T22:00:10.523357+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "GILD", "name": "Gilead Sciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "O'DAY, DANIEL PATRICK", "executive_title": "Director, Chairman & CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11900.0, "share_price": 126.0897, "transaction_value": 1500467.43, "fetched_at": "2026-07-22T10:58:18.509383+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/gild/", "research_links": {"chart": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/", "report": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/report/", "factor": "/factors/ticker/bed0290f-10c3-46eb-9ae3-e4a990955009/"}}, {"symbol": "GILD", "name": "Gilead Sciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "O'DAY, DANIEL PATRICK", "executive_title": "Director, Chairman & CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3100.0, "share_price": 127.075, "transaction_value": 393932.5, "fetched_at": "2026-07-22T10:58:18.511258+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/gild/", "research_links": {"chart": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/", "report": "/terminal/bed0290f-10c3-46eb-9ae3-e4a990955009/report/", "factor": "/factors/ticker/bed0290f-10c3-46eb-9ae3-e4a990955009/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "KEENAN, DAVID PAUL", "executive_title": "EVP, Chief Operating Officer", "security_type": "American Depositary Shares", "side_code": "D", "side": "Disposal", "shares": 1926.0, "share_price": 15.94, "transaction_value": 30700.44, "fetched_at": "2026-07-22T22:00:10.544313+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "KETCHUM, STEVEN B", "executive_title": "EVP, Chief Scientific Officer", "security_type": "American Depositary Shares", "side_code": "D", "side": "Disposal", "shares": 1887.0, "share_price": 15.94, "transaction_value": 30078.78, "fetched_at": "2026-07-22T22:00:10.540410+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "PROVOOST, JONATHAN", "executive_title": "EVP, Chief Legal Officer", "security_type": "American Depositary Shares", "side_code": "D", "side": "Disposal", "shares": 1264.0, "share_price": 15.94, "transaction_value": 20148.16, "fetched_at": "2026-07-22T22:00:10.528912+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "FISHMAN, PETER L.", "executive_title": "SVP, CFO", "security_type": "American Depositary Shares", "side_code": "D", "side": "Disposal", "shares": 1206.0, "share_price": 15.94, "transaction_value": 19223.64, "fetched_at": "2026-07-22T22:00:10.532940+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "FISHMAN, PETER L.", "executive_title": "SVP, CFO", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 2447.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T22:00:10.534957+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "KEENAN, DAVID PAUL", "executive_title": "EVP, Chief Operating Officer", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 3688.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T22:00:10.536548+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "KETCHUM, STEVEN B", "executive_title": "EVP, Chief Scientific Officer", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 3688.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T22:00:10.546373+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-07-01", "executive": "PROVOOST, JONATHAN", "executive_title": "EVP, Chief Legal Officer", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 3688.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T22:00:10.526867+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "BMY", "name": "Bristol-Myers Squibb Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "SAMUELS, THEODORE R. II", "executive_title": "Director", "security_type": "Deferred Share Units", "side_code": "A", "side": "Acquisition", "shares": 889.448, "share_price": 57.62, "transaction_value": 51249.9938, "fetched_at": "2026-07-20T21:48:28.674974+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bmy/", "research_links": {"chart": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/", "report": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/report/", "factor": "/factors/ticker/d302e92e-0d9f-411a-8823-7efba73d07cd/"}}, {"symbol": "BMY", "name": "Bristol-Myers Squibb Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "RICE, DERICA W", "executive_title": "Director", "security_type": "Deferred Share Units", "side_code": "A", "side": "Acquisition", "shares": 672.51, "share_price": 57.62, "transaction_value": 38750.0262, "fetched_at": "2026-07-20T21:48:28.667466+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bmy/", "research_links": {"chart": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/", "report": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/report/", "factor": "/factors/ticker/d302e92e-0d9f-411a-8823-7efba73d07cd/"}}, {"symbol": "BMY", "name": "Bristol-Myers Squibb Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "ARDUINI, PETER J", "executive_title": "Director", "security_type": "Deferred Share Units", "side_code": "A", "side": "Acquisition", "shares": 607.428, "share_price": 57.62, "transaction_value": 35000.0014, "fetched_at": "2026-07-20T21:48:28.671542+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bmy/", "research_links": {"chart": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/", "report": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/report/", "factor": "/factors/ticker/d302e92e-0d9f-411a-8823-7efba73d07cd/"}}, {"symbol": "BMY", "name": "Bristol-Myers Squibb Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "MCMULLEN, MICHAEL R.", "executive_title": "Director", "security_type": "Deferred Share Units", "side_code": "A", "side": "Acquisition", "shares": 607.428, "share_price": 57.62, "transaction_value": 35000.0014, "fetched_at": "2026-07-20T21:48:28.669716+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bmy/", "research_links": {"chart": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/", "report": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/report/", "factor": "/factors/ticker/d302e92e-0d9f-411a-8823-7efba73d07cd/"}}, {"symbol": "BMY", "name": "Bristol-Myers Squibb Company", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "YALE, PHYLLIS R", "executive_title": "Director", "security_type": "Deferred Share Units", "side_code": "A", "side": "Acquisition", "shares": 607.428, "share_price": 57.62, "transaction_value": 35000.0014, "fetched_at": "2026-07-20T21:48:28.673233+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bmy/", "research_links": {"chart": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/", "report": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/report/", "factor": "/factors/ticker/d302e92e-0d9f-411a-8823-7efba73d07cd/"}}, {"symbol": "ABBV", "name": "AbbVie Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "RAPP, EDWARD J", "executive_title": "Director", "security_type": "Stock Equivalent Units", "side_code": "A", "side": "Acquisition", "shares": 134.0, "share_price": 251.64, "transaction_value": 33719.76, "fetched_at": "2026-07-20T21:46:36.539182+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/abbv/", "research_links": {"chart": "/terminal/9a54a5f7-3445-44e1-a263-af644888772e/", "report": "/terminal/9a54a5f7-3445-44e1-a263-af644888772e/report/", "factor": "/factors/ticker/9a54a5f7-3445-44e1-a263-af644888772e/"}}, {"symbol": "MRK", "name": "Merck & Company Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "COE, MARY ELLEN", "executive_title": "Director", "security_type": "Phantom Stock", "side_code": "A", "side": "Acquisition", "shares": 233.463, "share_price": 128.5, "transaction_value": 29999.9955, "fetched_at": "2026-07-20T21:46:53.374541+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mrk/", "research_links": {"chart": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/", "report": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/report/", "factor": "/factors/ticker/f6db1008-c56f-44d2-9216-b4268cb66ffa/"}}, {"symbol": "MRK", "name": "Merck & Company Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "KARSANBHAI, SURENDRALAL LANCA", "executive_title": "Director", "security_type": "Phantom Stock", "side_code": "A", "side": "Acquisition", "shares": 126.4591, "share_price": 128.5, "transaction_value": 16249.9944, "fetched_at": "2026-07-20T21:46:53.383162+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mrk/", "research_links": {"chart": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/", "report": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/report/", "factor": "/factors/ticker/f6db1008-c56f-44d2-9216-b4268cb66ffa/"}}, {"symbol": "ABBV", "name": "AbbVie Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "QUAGGIN, SUSAN E", "executive_title": "Director", "security_type": "Stock Equivalent Units", "side_code": "A", "side": "Acquisition", "shares": 62.0, "share_price": 251.64, "transaction_value": 15601.68, "fetched_at": "2026-07-20T21:46:36.545159+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/abbv/", "research_links": {"chart": "/terminal/9a54a5f7-3445-44e1-a263-af644888772e/", "report": "/terminal/9a54a5f7-3445-44e1-a263-af644888772e/report/", "factor": "/factors/ticker/9a54a5f7-3445-44e1-a263-af644888772e/"}}, {"symbol": "MRK", "name": "Merck & Company Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "SEIDMAN, CHRISTINE E", "executive_title": "Director", "security_type": "Phantom Stock", "side_code": "A", "side": "Acquisition", "shares": 63.2296, "share_price": 128.5, "transaction_value": 8125.0036, "fetched_at": "2026-07-20T21:46:53.385969+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mrk/", "research_links": {"chart": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/", "report": "/terminal/f6db1008-c56f-44d2-9216-b4268cb66ffa/report/", "factor": "/factors/ticker/f6db1008-c56f-44d2-9216-b4268cb66ffa/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-30", "executive": "BOURLA, ALBERT", "executive_title": "Director, Chairman & CEO", "security_type": "Phantom Stock Units SSP", "side_code": "A", "side": "Acquisition", "shares": 25.0, "share_price": 24.08, "transaction_value": 602.0, "fetched_at": "2026-07-20T21:47:52.878585+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "BERG, AARON", "executive_title": "President and CEO", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 6250.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-17T11:06:26.264398+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "BERG, AARON", "executive_title": "President and CEO", "security_type": "American Depositary Shares", "side_code": "D", "side": "Disposal", "shares": 3197.0, "share_price": 16.35, "transaction_value": 52270.95, "fetched_at": "2026-07-17T11:06:26.260645+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "NARAYEN, SHANTANU", "executive_title": "Director", "security_type": "Phantom Stock Units", "side_code": "A", "side": "Acquisition", "shares": 2058.46, "share_price": 24.29, "transaction_value": 49999.9934, "fetched_at": "2026-07-16T22:03:54.520710+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "ECHEVARRIA, JOSEPH", "executive_title": "Director", "security_type": "Phantom Stock Units", "side_code": "A", "side": "Acquisition", "shares": 1904.076, "share_price": 24.29, "transaction_value": 46250.006, "fetched_at": "2026-07-16T22:03:54.519070+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "SMITH, JAMES C", "executive_title": "Director", "security_type": "Phantom Stock Units", "side_code": "A", "side": "Acquisition", "shares": 1852.614, "share_price": 24.29, "transaction_value": 44999.9941, "fetched_at": "2026-07-16T22:03:54.522284+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "QUINCEY, JAMES", "executive_title": "Director", "security_type": "Phantom Stock Units", "side_code": "A", "side": "Acquisition", "shares": 1595.307, "share_price": 24.29, "transaction_value": 38750.007, "fetched_at": "2026-07-16T22:03:54.514170+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "BUCKLEY, MORTIMER J", "executive_title": "Director", "security_type": "Phantom Stock Units", "side_code": "A", "side": "Acquisition", "shares": 1543.845, "share_price": 24.29, "transaction_value": 37499.9951, "fetched_at": "2026-07-16T22:03:54.517441+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "PFE", "name": "Pfizer Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "TARAPOREVALA, CYRUS", "executive_title": "Director", "security_type": "Phantom Stock Units", "side_code": "A", "side": "Acquisition", "shares": 1543.845, "share_price": 24.29, "transaction_value": 37499.9951, "fetched_at": "2026-07-16T22:03:54.515846+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pfe/", "research_links": {"chart": "/terminal/932d750f-7374-4126-b519-14313f9c835e/", "report": "/terminal/932d750f-7374-4126-b519-14313f9c835e/report/", "factor": "/factors/ticker/932d750f-7374-4126-b519-14313f9c835e/"}}, {"symbol": "AMRN", "name": "Amarin Corporation PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General", "transaction_date": "2026-06-26", "executive": "BERG, AARON", "executive_title": "President and CEO", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 6250.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T11:06:26.248752+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/amrn/", "research_links": {"chart": "/terminal/45864420-8158-4459-a5ae-679989408c7c/", "report": "/terminal/45864420-8158-4459-a5ae-679989408c7c/report/", "factor": "/factors/ticker/45864420-8158-4459-a5ae-679989408c7c/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}